mounjaro and retatrutide Part 2 — continuing from where we left off., We finished on GIP how drugs like pushed results beyond GLP-1 alone., Now the conversation moves to — the next step people are The Truth About Weight Loss

Compounded semaglutide is considered an eligible medical expense when prescribed by a licensed provider for a diagnosed medical condition (obesity or type 2 diabetes)

But as with any powerful tool, context matters

Among the 12mg group, 58.6% achieved 25% or greater weight loss, 39.4% achieved 30% or greater, and 23.7% achieved 35% or greater

This is the same dual-agonist approach that made tirzepatide so effective, but retatrutide goes further

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are approved for treating type 2 diabetes and obesity and are under investigation as potential treatments for substance use disorders (SUD)

These new medications (if pure) are indeed powerful and helpful, when used appropriately